BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2019 6:57:46 AM | Browse: 837 | Download: 1058
 |
Received |
|
2019-08-09 14:57 |
|
Peer-Review Started |
|
2019-08-09 14:57 |
|
To Make the First Decision |
|
2019-09-27 00:18 |
|
Return for Revision |
|
2019-09-30 06:58 |
|
Revised |
|
2019-10-03 16:40 |
|
Second Decision |
|
2019-10-18 10:24 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-10-19 22:16 |
|
Articles in Press |
|
2019-10-19 22:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-10-26 00:13 |
|
Publish the Manuscript Online |
|
2019-12-02 06:57 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Review |
| Article Title |
Treatment of Early Stage (T1) Esophageal Adenocarcinoma: Personalizing the best therapy choice
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lindsay Danielle Kumble, Elisabeth Silver, Aaron Oh, Julian A. Abrams, Joshua R Sonett and Chin Hur |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chin Hur, MD, Doctor, Department of Medicine, Columbia University Irving Medical Center, Columbia University Irving Medical Center, 622 W. 168th St., Presbyterian Hospital 9‐105, New York, NY 10032, United States. ch447@cumc.columbia.edu |
| Key Words |
Esophageal cancer; Adenocarcinoma; T1b; Esophagectomy; Endoscopic resection; Chemoradiotherapy |
| Core Tip |
This paper is an important source of information for patients and clinicians faced with a diagnosis of T1b esophageal adenocarcinoma (T1b EAC). This paper explores and then outlines the potential benefits and risks of the numerous treatment options for T1b EAC, highlighting the integral role a patient’s individual wishes and values play into making a treatment decision that achieves the greatest outcome for that patient. The review advocates for further research regarding the effects of T1b EAC treatment options on a patient’s quality of life. |
| Publish Date |
2019-12-02 06:57 |
| Citation |
Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World J Meta-Anal 2019; 7(9): 406-417 |
| URL |
https://www.wjgnet.com/2308-3840/full/v7/i9/406.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v7.i9.406 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
